158 related articles for article (PubMed ID: 15020250)
1. Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation.
Carlson CJ; White MF; Rondinone CM
Biochem Biophys Res Commun; 2004 Apr; 316(2):533-9. PubMed ID: 15020250
[TBL] [Abstract][Full Text] [Related]
2. Roles of mTOR and JNK in serine phosphorylation, translocation, and degradation of IRS-1.
Hiratani K; Haruta T; Tani A; Kawahara J; Usui I; Kobayashi M
Biochem Biophys Res Commun; 2005 Sep; 335(3):836-42. PubMed ID: 16099428
[TBL] [Abstract][Full Text] [Related]
3. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of feedback regulation of insulin receptor substrate-1 phosphorylation in primary adipocytes.
Hers I; Tavaré JM
Biochem J; 2005 Jun; 388(Pt 2):713-20. PubMed ID: 15713122
[TBL] [Abstract][Full Text] [Related]
5. Insulin-induced stimulation of JNK and the PI 3-kinase/mTOR pathway leads to phosphorylation of serine 318 of IRS-1 in C2C12 myotubes.
Müssig K; Fiedler H; Staiger H; Weigert C; Lehmann R; Schleicher ED; Häring HU
Biochem Biophys Res Commun; 2005 Sep; 335(3):819-25. PubMed ID: 16099431
[TBL] [Abstract][Full Text] [Related]
6. Role of mTOR in the degradation of IRS-1: regulation of PP2A activity.
Hartley D; Cooper GM
J Cell Biochem; 2002; 85(2):304-14. PubMed ID: 11948686
[TBL] [Abstract][Full Text] [Related]
7. Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling.
Sharfi H; Eldar-Finkelman H
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E307-15. PubMed ID: 18029441
[TBL] [Abstract][Full Text] [Related]
8. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
Fang CX; Yang X; Sreejayan N; Ren J
Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
[TBL] [Abstract][Full Text] [Related]
9. PKCdelta and mTOR interact to regulate stress and IGF-I induced IRS-1 Ser312 phosphorylation in breast cancer cells.
Mingo-Sion AM; Ferguson HA; Koller E; Reyland ME; Van Den Berg CL
Breast Cancer Res Treat; 2005 Jun; 91(3):259-69. PubMed ID: 15952059
[TBL] [Abstract][Full Text] [Related]
10. Amino acids and leucine allow insulin activation of the PKB/mTOR pathway in normal adipocytes treated with wortmannin and in adipocytes from db/db mice.
Hinault C; Mothe-Satney I; Gautier N; Lawrence JC; Van Obberghen E
FASEB J; 2004 Dec; 18(15):1894-6. PubMed ID: 15479767
[TBL] [Abstract][Full Text] [Related]
11. mTOR partly mediates insulin resistance by phosphorylation of insulin receptor substrate-1 on serine(307) residues after burn.
Xin-Long C; Zhao-Fan X; Dao-Feng B; Wei D
Burns; 2011 Feb; 37(1):86-93. PubMed ID: 20594757
[TBL] [Abstract][Full Text] [Related]
12. Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: A crossroad between cancer and diabetes?
Di Paolo S; Teutonico A; Leogrande D; Capobianco C; Schena PF
J Am Soc Nephrol; 2006 Aug; 17(8):2236-44. PubMed ID: 16807405
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin partially prevents insulin resistance induced by chronic insulin treatment.
Berg CE; Lavan BE; Rondinone CM
Biochem Biophys Res Commun; 2002 May; 293(3):1021-7. PubMed ID: 12051762
[TBL] [Abstract][Full Text] [Related]
14. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1.
Haruta T; Uno T; Kawahara J; Takano A; Egawa K; Sharma PM; Olefsky JM; Kobayashi M
Mol Endocrinol; 2000 Jun; 14(6):783-94. PubMed ID: 10847581
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
[TBL] [Abstract][Full Text] [Related]
16. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.
Gual P; Le Marchand-Brustel Y; Tanti JF
Biochimie; 2005 Jan; 87(1):99-109. PubMed ID: 15733744
[TBL] [Abstract][Full Text] [Related]
17. The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARgamma agonist restores normal cell signaling and differentiation.
Sentinelli F; Filippi E; Cavallo MG; Romeo S; Fanelli M; Baroni MG
J Endocrinol; 2006 Feb; 188(2):271-85. PubMed ID: 16461553
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes.
Gao Z; Zhang X; Zuberi A; Hwang D; Quon MJ; Lefevre M; Ye J
Mol Endocrinol; 2004 Aug; 18(8):2024-34. PubMed ID: 15143153
[TBL] [Abstract][Full Text] [Related]
19. In human endothelial cells amino acids inhibit insulin-induced Akt and ERK1/2 phosphorylation by an mTOR-dependent mechanism.
Pellegatta F; Catapano AL; Luzi L; Terruzzi I
J Cardiovasc Pharmacol; 2006 May; 47(5):643-9. PubMed ID: 16775502
[TBL] [Abstract][Full Text] [Related]
20. The Mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man.
Krebs M; Brunmair B; Brehm A; Artwohl M; Szendroedi J; Nowotny P; Roth E; Fürnsinn C; Promintzer M; Anderwald C; Bischof M; Roden M
Diabetes; 2007 Jun; 56(6):1600-7. PubMed ID: 17329620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
